105 related articles for article (PubMed ID: 1485583)
1. [Present status and controversy of treatment for renal cell carcinoma].
Ozono S; Takashima K; Yoshikawa M; Hirao Y; Okajima E
Hinyokika Kiyo; 1992 Nov; 38(11):1285-92. PubMed ID: 1485583
[TBL] [Abstract][Full Text] [Related]
2. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
3. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
[TBL] [Abstract][Full Text] [Related]
4. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
[TBL] [Abstract][Full Text] [Related]
5. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
[TBL] [Abstract][Full Text] [Related]
6. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
7. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
8. [The evaluation of surgical management for metastatic lesions of renal cell carcinoma].
Watanabe M; Kitamura Y; Komatsubara S; Sakata Y
Hinyokika Kiyo; 1995 Nov; 41(11):847-53. PubMed ID: 8533685
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
[TBL] [Abstract][Full Text] [Related]
10. Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.
Kwak C; Park YH; Jeong CW; Jeong H; Lee SE; Moon KC; Ku JH
J Surg Oncol; 2007 Mar; 95(4):317-23. PubMed ID: 17066434
[TBL] [Abstract][Full Text] [Related]
11. [Definition of early renal cell carcinoma--from the study of pathological and clinical findings according to tumor size].
Kitamura Y; Watanabe M; Komatubara S; Sakata Y
Hinyokika Kiyo; 1995 Jul; 41(7):511-5. PubMed ID: 7668180
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers.
Mani S; Todd MB; Katz K; Poo WJ
J Urol; 1995 Jul; 154(1):35-40. PubMed ID: 7539867
[TBL] [Abstract][Full Text] [Related]
13. Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation.
Nakayama K; Tannir NM; Liu P; Wathen JK; Cheng YC; Champlin RE; Ueno NT
Biol Blood Marrow Transplant; 2007 Aug; 13(8):975-85. PubMed ID: 17640602
[TBL] [Abstract][Full Text] [Related]
14. [Management of advanced renal cell carcinoma: surgical treatment of metastasis].
Kinouchi T; Kotake T
Hinyokika Kiyo; 1994 Oct; 40(10):919-24. PubMed ID: 7992709
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of postoperative interferon-alpha adjuvant therapy for non-metastatic renal cell carcinoma.
Gotoh A; Shirakawa T; Hinata N; Wada Y; Hara I; Fujisawa M; Kawabata G; Okada H; Arakawa S; Kamidono S
Int J Urol; 2004 May; 11(5):257-63. PubMed ID: 15147539
[TBL] [Abstract][Full Text] [Related]
16. [Influential clinical and pathological factors on prognosis of renal cell carcinoma].
Saika T; Yamamoto Y; Takeda K; Asahi T
Hinyokika Kiyo; 1994 Mar; 40(3):189-93. PubMed ID: 7513936
[TBL] [Abstract][Full Text] [Related]
17. Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.
Horiguchi A; Oya M; Shimada T; Uchida A; Marumo K; Murai M
J Urol; 2002 Aug; 168(2):762-5. PubMed ID: 12131365
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study of the patients with renal cell carcinoma before and after 1980].
Onishi T; Machida T; Masuda F; Suzuki M; Furuta N
Hinyokika Kiyo; 1990 Aug; 36(8):879-85. PubMed ID: 2239588
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma in children. Prognostic factors.
Al-Shabanah MO; Jenkin DR; Khafaga YO; Al-Zahrani AM; Danjoux C; Greenberg M
Saudi Med J; 2004 Nov; 25(11):1583-6. PubMed ID: 15573183
[TBL] [Abstract][Full Text] [Related]
20. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.
Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz B; Belldegrun AS; Figlin RA
Cancer; 2003 Jun; 97(12):2995-3002. PubMed ID: 12784334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]